I'm having an argument with a doctor right now on this very point. He insists that the highlighted text doesn't mean that; just that the new test must (like its predecessor, the PCR) be able to distinguish flu and covid.
I think he's full of bullshit but normies are impressed with his white coat and stethoscope.
I must need to learn the nuances as well, because my understanding of that sentence was and is the same as the doctor's. It doesn't say anything about the old test -- just lists suggested minimum requirements for the subsequent one. Presumably there is a reason they are phasing it out, but they don't mention it in this piece.
Because "adoption of a multiplexed method that can facilitate 'detection and differentiation of SARS-CoV-2 and influenza viruses' " means there is not a current capability in the existing tests. Otherwise they wouldn't need to adopt one. And those who need to adopt one were already using the CDC 2019 nCoV RT-PCR assay select, meaning that was likely the best available.
I should clarify further. Detection and differentiation of COVID and influenza means they look the same to the current test and they need something that can tell them apart. So the current test since 2019 has had no idea what it was looking at and they want a multiplexed method (can see more than one).
It's been bullshit this whole time. People have just been dying of flu, some of COVID, but we have no idea how many of each.
I'm having an argument with a doctor right now on this very point. He insists that the highlighted text doesn't mean that; just that the new test must (like its predecessor, the PCR) be able to distinguish flu and covid.
I think he's full of bullshit but normies are impressed with his white coat and stethoscope.
Yeah, he needs to learn the nuances of English.
I must need to learn the nuances as well, because my understanding of that sentence was and is the same as the doctor's. It doesn't say anything about the old test -- just lists suggested minimum requirements for the subsequent one. Presumably there is a reason they are phasing it out, but they don't mention it in this piece.
Because "adoption of a multiplexed method that can facilitate 'detection and differentiation of SARS-CoV-2 and influenza viruses' " means there is not a current capability in the existing tests. Otherwise they wouldn't need to adopt one. And those who need to adopt one were already using the CDC 2019 nCoV RT-PCR assay select, meaning that was likely the best available.
I should clarify further. Detection and differentiation of COVID and influenza means they look the same to the current test and they need something that can tell them apart. So the current test since 2019 has had no idea what it was looking at and they want a multiplexed method (can see more than one).
It's been bullshit this whole time. People have just been dying of flu, some of COVID, but we have no idea how many of each.
Annnd...new test made by? Gates?!!